Fresenius Medical Care (ETR:FME) Stock Passes Above 200-Day Moving Average – Time to Sell?

Fresenius Medical Care AG (ETR:FME) shares passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of €45.75 ($53.20) and traded as high as €47.23 ($54.92). Fresenius Medical Care shares last traded at €47.17 ($54.85), with a volume of 466,778 shares traded.

Fresenius Medical Care Stock Performance

The firm has a market cap of $13.75 billion, a PE ratio of 20.86, a price-to-earnings-growth ratio of 0.42 and a beta of 0.86. The company has a 50 day simple moving average of €44.14 and a 200-day simple moving average of €45.75. The company has a debt-to-equity ratio of 82.24, a current ratio of 1.37 and a quick ratio of 0.80.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.